Member Info for Henners007

You do not need a prescription for Eroxxon.

Surfie 1961, shall we let the hard sales do the talking rather than the soft airhead keyboard warriors?

Spot on dosanddonts. Precisely same narrative as when initially sold in UK and Europe 12/18 months ago. Medically and scientifically proven it works in 60% of people. In todays society, always the minority that shout loudest and get heard, and in Eroxon's case the 40% who it won't help are shouting it from the roof tops.

Got to agree. After the last fund raise at 1p SCE simply has nowhere to go. The previous bottlenecks have not been resolved from reading that RNS. Difficult to see where SCE goes from here. All the financial expectations, extrapolations and predictions have simply gone up in smoke. 40% behind budget is a mahoooosive number in such a short timeframe.

Dracula1 - you are asking for people gambling on horses to get their stake back if their horse doesn't win. It ain't ever going to happen. Caveat emptor.

Before investors stake their money in VAL or any other company, they have access to a whole raft of information, upon which they make their call. In AIM stocks, the buyer needs to take a much closer look before they leap, than if investing in a FTSE100 share.

As an investor who has made and lost money over the years, I would never seek to blame others for my foolhardy/loss making investments. Never ever invest more than you can afford to lose. We all do of course, but who should we blame.................only ourselves.

CBG was a private merchant bank, founded in 1878, which had some associated lending as part of its broader offering.

Part of this offering (the asset management business) has now been sold as a direct result of the FCA ongoing enquiry, to improve liquidity. Pulling up the drawbridge if you like and preserving what you have ahead of the storm arriving.

The FCA enquiry will take a long time. CBG will have an internal team and an external team currently working through each individual case to establish whether there is likely to be any wrongdoing, and likely cost of remediation. The cost of the review and enquiry will run into £millions. There is no quick fix, either to the ongoing review or the share price. A once august, city loved, FTSE250 company is fighting for its continued existence. It would not be surprising to see other parts of the bank sold off (eg Winterfloods?!). Sadly, it has become a gamblers bet on whether it can persuade the FCA of its innocence.

Abbey National went exactly the same way after overweighting its loan book away from its core residential mortgages (ie Porterbrook train leasing).

That is a fire sale of CBAM.

FCA could easily delay/defer/procrastinate for another couple of years. Will be fascinating to see over the next few days how analysts view this transaction.

There was a lot of generic non committal wording in the announcement.

Great name, strong brand has now entered into a thick fog that is the FCA. Anyone familiar with Amigo?!! Take care, wide berth required unless you are a financial thrill seeker.

I feel relatively confident that a company with a mkt cap of £35bn will have carried out their due diligence!! Excited by tomorrows sp more than todays. Hopefully when the yanks wake up and lubricate their brains to the power of Eroxon we should see some firm price action.

Credit to Do's and Dont's post today @ 09:48

https://www.amazon.com/Eroxon-Erectile-Dysfunction-Treatment-Clinically/dp/B0DBWQH8N1/ref=mp_s_a_1_1?dib=eyJ2IjoiMSJ9.qyLI196IUz1sCRrQRbzltVtcmarO91DeM1HIcnzd14SU7QU1JKIsEj7jbXStNEa6d4RZNoOkJ8ECpdSRRaEm-9YWMFGjFqST3DGvuJELws54ZsZ8uVwd5hvFr5AMQsqTzYto4Sm6gt2V88IngeLj6micGC32ZVpg4WxHcS6ixc67epQ9DgM_sAppg7P3FbO6CFy28hmgXXES4vkEOUvOBw.ShHHX6CXDn9CeIW-2oNk7tDu8CP_wUG7m9tmrZz7iU4&dib_tag=se&keywords=eroxon+ed&qid=1725266686&sr=8-1

It definitely was not on Haleon website before todays RNS. Clear, concise and well thought out sales overview. The "big boys" like Haleon prefer winners to losers!!!

@ Launch has Eroxon at no.75 of top 100 sexual lubricants in US market on Amazon. Gotta watch this number over next month.

RNS carefully orchestrated methinks. Today is a public holiday in US. Labour Day.

Fascinating. I have come to view LGEN as something of an anachronism in todays investing world.

Since the change of accounting for profit with the insurers, the market appears to have been bamboozled by what this means in practice and I am not sure I have any better idea than others, but when I read in the recently released financial statements that "Growth in our store of future profit: up 7% year on year to £14.5bn4" - my ears prick up. That is an awful lot of store of future profit. And while nothing is guaranteed, a gently falling interest rate environment should be positive for the share price of LGEN, and that "store of future profit" is never likely to be a negative.

Yes happy to be educated on your "bond yield like DCF calcs" at sdhennersatgmaildotcom

Hi Ellltelinv,

The interest charges on the debt are to be reduced by £18m p.a. + the debt pile will be reduced + earnings accretive immediately. That alone should allay concerns and improve sp.

With a current net asset value of 95.75p per share (and Englands stunning victory last night!!! which will undoubtedly provide a cash windfall) the corner has hopefully finally been turned with MARS

Hi Jedclampit,

Why do you say they were free shares? As far as I can see (from the RNS) they were acquired (paid for). Happy(ish) to be proved wrong but please provide evidence.

The Coy has alway stated they would get debt down below £1bn before end of this financial year. That was one of their much quoted KPI's. And they have achieved. Well done the BoD.

Regarding value, if the company was sold tomorrow at fair value (fully accept there might be some small vagaries) it would be worth very close to £600m and not £250m MC today. FACT. The £600m is based on present value and allows no premium for enterprise value.

Jedclampit - That is not how MC works.

The current MC takes full account of the debt. Without the debt (all other things being equal) & based on your figures, the company would be worth £1.25bn. The audited value per share as at 9/23 including debt was 95.75p per share.

The sale of the Carlsberg stake should increase that value given Marstons have confirmed via RNS that the sale is earnings accretive immediately.

This is why many existing and potential investors are starting to get turned on to the low current value, presently trading at somewhere close to 70% discount to NPV. Hence my previous post of "price is what you pay and value is what you get."

The Directors are aware of the sp anomaly which probably helps explain why they have all been buying shares strongly over the last couple of years. Exciting times ahead and I will drink to that.

I think you are looking at this the wrong way round.

MARS are saving £18m debt interest by paying down part of their debt pile by trousering £206m from the sale of their Carlsberg stake. They state this transaction will be earnings accretive from the date of the transaction. That is very good news.

A company with a net total market cap of c£250m has just received £206m without impacting its core business. On that basis the core pub business is valued at c£50m. Absolute madness.

Price is what you pay and value is what you get. IMHO this share is even more undervalued post this transaction.

Stockpot - by chance have you read the RNS? CH uses the very word you wanted to read/hear!!!! He also used the word “delighted”. Good eh?

OMG. There are some frumpy, grumpy, grizzly individuals invested in FUM. Please take the palatable pink Patience pill.

Value is what something is worth not what you pay for it.

Ps we may have to wait just a little longer to find out what FUM is worth.

Loving it. Aviva pile in and buy 5.5m shares from a nil holding base, total value circa £150m. Now that is confidence. Follow the money..............................................

Mucic is the Chief Financial Officer. Follow the man follow the money!!

Del Valle has over 7m shares and has made significant purchases within the last couple of years. They clearly both have much confidence in the Company they are "managing".